Ginkgo Bioworks Holdings, Inc. Class A is a company in the U.S. stock market and it is a holding in 52 U.S.-traded ETFs. DNA has around 159.9M shares in the U.S. ETF market. The largest ETF holder of DNA is the ARK Innovation ETF (ARKK), with approximately 85.08M shares. Investors may also find of interest that the ETF with the largest allocation to DNA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 4.28%. On average, U.S. ETFs allocate 0.43% of DNA to their portfolios.
Additionally, DNA is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DNA as a holding is the VegTech Plant-based Innovation & Climate ETF (EATV), with a return of --.